La Fundación La Marató de TV3 organiza el evento anual «La Marató 2024», que busca recaudar fondos para la investigación científica de enfermedades que no tienen cura
The diagnosis of COPD requires the demonstration of non-fully reversible airflow limitation by spirometry in the appropriate clinical context.
The COPD Foundation is kicking off its 20th anniversary year with exciting news! Bronchiectasis and NTM 360, a division of the COPD Foundation, is thrilled to announce its journey to establish a Bronchiectasis and NTM Care Center Network.
The treatable traits approach represents a strategy for patient management. It is based on the identification of characteristics susceptible to treatments or predictive of treatment response in each individual patient.
We explore this concept and look at atopic dermatitis, chronic rhinosinusitis with nasal polyps, etc., as treatable traits of asthma and how these can be managed.
El neumólogo e investigador de Barcelona Respiratory Network pide realizar este tipo de pruebas para detectar precozmente esta patología
El 23 y 24 de febrero de 2024 se celebra la 11ª Edición Barcelona Boston Lung Conference. Presentación de 12 abstracts de entre todos los abstracts recibidos.
El 08/05/2024 se celebrará la 1ª Edición de RESPrimaria, jornada dedicada a la actualización de la neumología en Atención Primaria. Posibilidad de asistencia presencial y online.
To investigate it, we calculated immune signatures with Gene Set Variation Analysis (GSVA) and applied them to the lung transcriptome followed by unbiased cluster analysis of GSVA immune-enrichment scores, in 109 IPF patients from the Lung Tissue Research Consortium (LTRC)
Since 2001 the GOLD publishes and updates every year a document that recommends how to best diagnose and manage COPD. The GOLD 2024 document has just been released and is available for free download in the GOLD website.
